$ICN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VALEANT PHARMACEUTICALS INTERNATIONAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VALEANT PHARMACEUTICALS INTERNATIONAL. Get notifications about new insider transactions in VALEANT PHARMACEUTICALS INTERNATIONAL for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 27 2015 | ICN | VALEANT PHARMACEUT ... | UBBEN JEFFREY W | Director | Payment of Exercise | F | 224.63 | 124 | 27,854 | 3,117 | 3.2 K to 3.1 K (-3.83 %) |
May 27 2015 | ICN | VALEANT PHARMACEUT ... | UBBEN JEFFREY W | Director | Grant | A | 0.00 | 1,607 | 0 | 3,241 | 1.6 K to 3.2 K (+98.35 %) |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP, Chief Financia ... | Option Exercise | D | 38.47 | 97,948 | 3,768,060 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP, Chief Financia ... | Option Exercise | D | 23.92 | 4,180 | 99,986 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP, Chief Financia ... | Option Exercise | D | 23.92 | 15,820 | 378,414 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP, Chief Financia ... | Option Exercise | D | 18.55 | 13,500 | 250,425 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP, Chief Financia ... | Option Exercise | D | 14.80 | 29,732 | 440,034 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP, Chief Financia ... | Option Exercise | D | 14.80 | 20,268 | 299,966 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP, Chief Financia ... | Option Exercise | D | 18.68 | 45,000 | 840,600 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP, Chief Financia ... | Option Exercise | D | 17.72 | 34,000 | 602,480 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP, Chief Financia ... | Option Exercise | D | 16.76 | 26,136 | 438,039 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP, Chief Financia ... | Option Exercise | D | 16.76 | 23,864 | 399,961 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP, Chief Financia ... | Sell | D | 0.00 | 216,889 | 0 | 0 | 216.9 K to 0 (-100.00 %) |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Option Exercise | D | 38.47 | 74,627 | 2,870,901 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Option Exercise | D | 22.68 | 81,143 | 1,840,323 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Option Exercise | D | 22.68 | 13,986 | 317,202 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Sell | D | 0.00 | 261,994 | 0 | 0 | 262 K to 0 (-100.00 %) |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP, General Counse ... | Option Exercise | D | 38.47 | 83,955 | 3,229,749 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP, General Counse ... | Option Exercise | D | 17.11 | 75,923 | 1,299,043 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP, General Counse ... | Option Exercise | D | 17.11 | 23,376 | 399,963 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP, General Counse ... | Sell | D | 0.00 | 213,069 | 0 | 0 | 213.1 K to 0 (-100.00 %) |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman | Option Exercise | D | 37.41 | 500,000 | 18,705,000 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman | Option Exercise | D | 12.19 | 1,024,591 | 12,489,764 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman | Sell | D | 0.00 | 1,931,505 | 0 | 0 | 1.9 M to 0 (-100.00 %) |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP, Chief Admin Of ... | Option Exercise | D | 38.47 | 55,970 | 2,153,166 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP, Chief Admin Of ... | Option Exercise | D | 15.47 | 99,144 | 1,533,758 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP, Chief Admin Of ... | Option Exercise | D | 15.47 | 25,856 | 399,992 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP, Chief Admin Of ... | Sell | D | 0.00 | 218,663 | 0 | 0 | 218.7 K to 0 (-100.00 %) |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Option Exercise | D | 38.47 | 74,627 | 2,870,901 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Option Exercise | D | 16.63 | 164,212 | 2,730,846 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Option Exercise | D | 16.63 | 20,756 | 345,172 | 0 | |
Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Sell | D | 0.00 | 333,438 | 0 | 0 | 333.4 K to 0 (-100.00 %) |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | Morfit G Mason | Director | Buy | D | 0.00 | 24,687 | 0 | 0 | -24,687 to 0 (-100.00 %) |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Sell | D | 0.00 | 15,138,358 | 0 | 0 | 15.1 M to 0 (-100.00 %) |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Sell | D | 0.00 | 24,687 | 0 | 0 | 24.7 K to 0 (-100.00 %) |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Option Exercise | D | 8.12 | 10,000 | 81,200 | 0 | |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Sell | D | 0.00 | 55,589 | 0 | 0 | 55.6 K to 0 (-100.00 %) |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Sell | D | 0.00 | 39,574 | 0 | 0 | 39.6 K to 0 (-100.00 %) |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Sell | D | 0.00 | 12,766 | 0 | 0 | 12.8 K to 0 (-100.00 %) |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Option Exercise | D | 10.05 | 15,000 | 150,750 | 0 | |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Sell | D | 0.00 | 54,523 | 0 | 0 | 54.5 K to 0 (-100.00 %) |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Sell | D | 0.00 | 60,627 | 0 | 0 | 60.6 K to 0 (-100.00 %) |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Sell | D | 0.00 | 79,053 | 0 | 0 | 79.1 K to 0 (-100.00 %) |
Sep 30 2010 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Sell | D | 0.00 | 10,902 | 0 | 0 | 10.9 K to 0 (-100.00 %) |
Jul 06 2010 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Grant | A | 0.00 | 135 | 0 | 19,707 | 19.6 K to 19.7 K (+0.69 %) |
Aug 24 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Payment of Exercise | F | 57.02 | 1,343 | 76,578 | 94,101 | 95.4 K to 94.1 K (-1.41 %) |
Aug 24 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Payment of Exercise | F | 57.02 | 1,044 | 59,529 | 95,444 | 96.5 K to 95.4 K (-1.08 %) |
Jul 06 2010 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 406 | 0 | 43,117 | 42.7 K to 43.1 K (+0.95 %) |
Jul 06 2010 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 369 | 0 | 47,646 | 47.3 K to 47.6 K (+0.78 %) |
Jul 06 2010 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Grant | A | 0.00 | 320 | 0 | 12,766 | 12.4 K to 12.8 K (+2.57 %) |
Jul 06 2010 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 357 | 0 | 37,608 | 37.3 K to 37.6 K (+0.96 %) |
Jul 06 2010 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 153 | 0 | 30,542 | 30.4 K to 30.5 K (+0.50 %) |
Jul 06 2010 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 345 | 0 | 42,864 | 42.5 K to 42.9 K (+0.81 %) |
Jul 01 2010 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Payment of Exercise | F | 52.29 | 328 | 17,151 | 59,909 | 60.2 K to 59.9 K (-0.54 %) |
Jul 01 2010 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Payment of Exercise | F | 52.29 | 709 | 37,074 | 60,237 | 60.9 K to 60.2 K (-1.16 %) |
Jun 11 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Option Exercise | M | 22.68 | 18,338 | 415,906 | 81,143 | |
Jun 11 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Option Exercise | M | 22.68 | 4,662 | 105,734 | 13,986 | |
Jun 11 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Sell | S | 45.24 | 18,338 | 829,650 | 96,488 | 114.8 K to 96.5 K (-15.97 %) |
Jun 11 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Buy | M | 22.68 | 18,338 | 415,906 | 114,826 | 96.5 K to 114.8 K (+19.01 %) |
Jun 11 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Sell | S | 45.24 | 4,662 | 210,919 | 96,488 | 101.2 K to 96.5 K (-4.61 %) |
Jun 11 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Buy | M | 22.68 | 4,662 | 105,734 | 101,150 | 96.5 K to 101.2 K (+4.83 %) |
May 13 2010 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Grant | A | 0.00 | 2,677 | 0 | 24,687 | 22 K to 24.7 K (+12.16 %) |
May 13 2010 | ICN | VALEANT PHARMACEUT ... | Morfit G Mason | Director | Grant | A | 0.00 | 2,677 | 0 | 24,687 | 22 K to 24.7 K (+12.16 %) |
May 13 2010 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Grant | A | 0.00 | 2,677 | 0 | 19,572 | 16.9 K to 19.6 K (+15.84 %) |
May 13 2010 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 2,677 | 0 | 42,711 | 40 K to 42.7 K (+6.69 %) |
May 13 2010 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 2,677 | 0 | 47,277 | 44.6 K to 47.3 K (+6.00 %) |
May 13 2010 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Grant | A | 0.00 | 2,677 | 0 | 12,446 | 9.8 K to 12.4 K (+27.40 %) |
May 13 2010 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 2,677 | 0 | 37,251 | 34.6 K to 37.3 K (+7.74 %) |
May 13 2010 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 2,677 | 0 | 30,389 | 27.7 K to 30.4 K (+9.66 %) |
May 13 2010 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 3,500 | 0 | 42,519 | 39 K to 42.5 K (+8.97 %) |
May 04 2010 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Sell | S | 40.41 | 2,637,545 | 106,583,193 | 15,138,358 | 17.8 M to 15.1 M (-14.84 %) |
Apr 07 2010 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Payment of Exercise | F | 44.05 | 759 | 33,434 | 82,505 | 83.3 K to 82.5 K (-0.91 %) |
Apr 07 2010 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Payment of Exercise | F | 44.05 | 195 | 8,590 | 83,264 | 83.5 K to 83.3 K (-0.23 %) |
Apr 07 2010 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Payment of Exercise | F | 44.05 | 197 | 8,678 | 83,459 | 83.7 K to 83.5 K (-0.24 %) |
Apr 07 2010 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Payment of Exercise | F | 44.05 | 484 | 21,320 | 83,656 | 84.1 K to 83.7 K (-0.58 %) |
Apr 05 2010 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Grant | A | 0.00 | 201 | 0 | 16,895 | 16.7 K to 16.9 K (+1.20 %) |
Apr 05 2010 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 476 | 0 | 40,034 | 39.6 K to 40 K (+1.20 %) |
Apr 05 2010 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 434 | 0 | 44,600 | 44.2 K to 44.6 K (+0.98 %) |
Apr 05 2010 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Grant | A | 0.00 | 376 | 0 | 9,769 | 9.4 K to 9.8 K (+4.00 %) |
Apr 05 2010 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 419 | 0 | 34,574 | 34.2 K to 34.6 K (+1.23 %) |
Apr 05 2010 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 180 | 0 | 27,712 | 27.5 K to 27.7 K (+0.65 %) |
Apr 05 2010 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 405 | 0 | 39,019 | 38.6 K to 39 K (+1.05 %) |
Mar 18 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Payment of Exercise | F | 39.86 | 436 | 17,379 | 90,489 | 90.9 K to 90.5 K (-0.48 %) |
Mar 05 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Option Exercise | A | 38.47 | 97,948 | 3,768,060 | 97,948 | |
Mar 05 2010 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Option Exercise | A | 0.00 | 35,084 | 0 | 35,084 | |
Mar 05 2010 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Option Exercise | A | 38.47 | 83,955 | 3,229,749 | 83,955 | |
Mar 05 2010 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Option Exercise | A | 0.00 | 30,072 | 0 | 30,072 | |
Mar 05 2010 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Option Exercise | A | 38.47 | 55,970 | 2,153,166 | 55,970 | |
Mar 05 2010 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Option Exercise | A | 0.00 | 20,048 | 0 | 20,048 | |
Mar 05 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Option Exercise | A | 38.47 | 74,627 | 2,870,901 | 74,627 | |
Mar 05 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Option Exercise | A | 0.00 | 26,731 | 0 | 26,731 | |
Mar 05 2010 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Option Exercise | A | 38.47 | 74,627 | 2,870,901 | 74,627 | |
Mar 05 2010 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Option Exercise | A | 0.00 | 26,731 | 0 | 26,731 | |
Mar 02 2010 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Buy | P | 37.28 | 3,300 | 123,024 | 16,694 | 13.4 K to 16.7 K (+24.64 %) |
Feb 03 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 33.72 | 21,252 | 716,617 | 1,004,198 | 1 M to 1 M (-2.07 %) |
Feb 03 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 33.72 | 4,627 | 156,022 | 1,025,450 | 1 M to 1 M (-0.45 %) |
Feb 03 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 33.72 | 5,961 | 201,005 | 1,030,077 | 1 M to 1 M (-0.58 %) |
Jan 22 2010 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Payment of Exercise | F | 34.27 | 2,143 | 73,441 | 96,488 | 98.6 K to 96.5 K (-2.17 %) |
Jan 05 2010 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Grant | A | 0.00 | 276 | 0 | 13,394 | 13.1 K to 13.4 K (+2.10 %) |
Jan 05 2010 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 650 | 0 | 39,558 | 38.9 K to 39.6 K (+1.67 %) |
Jan 05 2010 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 591 | 0 | 44,166 | 43.6 K to 44.2 K (+1.36 %) |
Jan 05 2010 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Grant | A | 0.00 | 512 | 0 | 9,393 | 8.9 K to 9.4 K (+5.77 %) |
Jan 05 2010 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 571 | 0 | 34,155 | 33.6 K to 34.2 K (+1.70 %) |
Jan 05 2010 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 247 | 0 | 27,532 | 27.3 K to 27.5 K (+0.91 %) |
Jan 05 2010 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 512 | 0 | 38,481 | 38 K to 38.5 K (+1.35 %) |
Dec 17 2009 | ICN | VALEANT PHARMACEUT ... | Blott Peter J | EVP & CFO | Payment of Exercise | F | 31.78 | 375 | 11,918 | 90,925 | 91.3 K to 90.9 K (-0.41 %) |
Dec 11 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Grant | A | 0.00 | 6,910 | 0 | 107,012 | 100.1 K to 107 K (+6.90 %) |
Dec 11 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Grant | A | 0.00 | 3,373 | 0 | 100,102 | 96.7 K to 100.1 K (+3.49 %) |
Dec 08 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 31.93 | 188,875 | 6,030,779 | 1,036,038 | 1.2 M to 1 M (-15.42 %) |
Dec 03 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Option Exercise | A | 37.41 | 500,000 | 18,705,000 | 500,000 | |
Dec 03 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Option Exercise | A | 0.00 | 173,750 | 0 | 173,750 | |
Dec 03 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Option Exercise | A | 0.00 | 200,481 | 0 | 200,481 | |
Nov 23 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Buy | P | 33.31 | 3,000 | 99,928 | 10,283 | 7.3 K to 10.3 K (+41.19 %) |
Nov 20 2009 | ICN | VALEANT PHARMACEUT ... | HealthCor Management, L.P. | 10% Owner | Sell | S | 32.25 | 3,000,000 | 96,750,000 | 7,000,000 | 10 M to 7 M (-30.00 %) |
Nov 20 2009 | ICN | VALEANT PHARMACEUT ... | HealthCor Offshore GP, LLC | 10% Owner | Sell | S | 32.25 | 3,000,000 | 96,750,000 | 7,000,000 | 10 M to 7 M (-30.00 %) |
Nov 19 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Buy | P | 33.58 | 2,385 | 80,097 | 7,283 | 4.9 K to 7.3 K (+48.69 %) |
Nov 12 2009 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Buy | P | 33.25 | 1,000 | 33,250 | 38,908 | 37.9 K to 38.9 K (+2.64 %) |
Nov 12 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Buy | P | 32.81 | 1,525 | 50,039 | 4,898 | 3.4 K to 4.9 K (+45.21 %) |
Nov 04 2009 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Buy | P | 30.82 | 1,635 | 50,391 | 13,118 | 11.5 K to 13.1 K (+14.24 %) |
Oct 05 2009 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Grant | A | 0.00 | 323 | 0 | 11,483 | 11.2 K to 11.5 K (+2.89 %) |
Oct 05 2009 | ICN | VALEANT PHARMACEUT ... | Provencio Norma Ann | Director | Grant | A | 0.00 | 763 | 0 | 37,908 | 37.1 K to 37.9 K (+2.05 %) |
Oct 05 2009 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 0.00 | 346 | 0 | 43,575 | 43.2 K to 43.6 K (+0.80 %) |
Oct 05 2009 | ICN | VALEANT PHARMACEUT ... | LONNER ANDERS | Director | Grant | A | 0.00 | 602 | 0 | 8,881 | 8.3 K to 8.9 K (+7.27 %) |
Oct 05 2009 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 0.00 | 335 | 0 | 33,584 | 33.2 K to 33.6 K (+1.01 %) |
Oct 05 2009 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 0.00 | 289 | 0 | 27,285 | 27 K to 27.3 K (+1.07 %) |
Oct 05 2009 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 602 | 0 | 37,969 | 37.4 K to 38 K (+1.61 %) |
Sep 14 2009 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Grant | A | 0.00 | 9,007 | 0 | 107,638 | 98.6 K to 107.6 K (+9.13 %) |
Sep 14 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Grant | A | 0.00 | 3,373 | 0 | 100,102 | 96.7 K to 100.1 K (+3.49 %) |
Sep 08 2009 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Buy | P | 26.03 | 2,875 | 74,822 | 14,035 | 11.2 K to 14 K (+25.76 %) |
Aug 25 2009 | ICN | VALEANT PHARMACEUT ... | DE SILVA RAJIV | Chief Operating Off ... | Buy | P | 24.98 | 9,007 | 224,995 | 98,631 | 89.6 K to 98.6 K (+10.05 %) |
Aug 17 2009 | ICN | VALEANT PHARMACEUT ... | CHAUDHURI BHASKAR | President | Buy | P | 26.69 | 3,373 | 90,026 | 3,373 | 0 to 3.4 K |
Aug 11 2009 | ICN | VALEANT PHARMACEUT ... | STEFANO STEPHEN F. | Director | Buy | P | 26.64 | 1,870 | 49,817 | 11,160 | 9.3 K to 11.2 K (+20.13 %) |
Aug 11 2009 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Payment of Exercise | F | 26.63 | 331 | 8,815 | 60,946 | 61.3 K to 60.9 K (-0.54 %) |
Aug 11 2009 | ICN | VALEANT PHARMACEUT ... | Min Steve T. | EVP and General Cou ... | Payment of Exercise | F | 26.63 | 712 | 18,961 | 61,277 | 62 K to 61.3 K (-1.15 %) |
Jul 28 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.97 | 300 | 7,491 | 17,775,903 | 17.8 M to 17.8 M (0.00 %) |
Jul 28 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.91 | 25,000 | 622,750 | 17,775,603 | 17.8 M to 17.8 M (+0.14 %) |
Jul 28 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.88 | 14,100 | 350,808 | 17,750,603 | 17.7 M to 17.8 M (+0.08 %) |
Jul 29 2009 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Payment of Exercise | F | 24.99 | 483 | 12,070 | 84,140 | 84.6 K to 84.1 K (-0.57 %) |
Jul 29 2009 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Payment of Exercise | F | 24.99 | 196 | 4,898 | 84,623 | 84.8 K to 84.6 K (-0.23 %) |
Jul 29 2009 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Payment of Exercise | F | 24.99 | 758 | 18,942 | 84,819 | 85.6 K to 84.8 K (-0.89 %) |
Jul 29 2009 | ICN | VALEANT PHARMACEUT ... | Karlson Elisa A. | EVP & Chief Adminis ... | Payment of Exercise | F | 24.99 | 194 | 4,848 | 85,577 | 85.8 K to 85.6 K (-0.23 %) |
Jul 27 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 24.73 | 5,960 | 147,391 | 1,224,913 | 1.2 M to 1.2 M (-0.48 %) |
Jul 27 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 24.73 | 22,945 | 567,430 | 1,230,873 | 1.3 M to 1.2 M (-1.83 %) |
Jul 27 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 24.73 | 5,898 | 145,858 | 1,253,818 | 1.3 M to 1.3 M (-0.47 %) |
Jul 23 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.75 | 25,000 | 618,750 | 17,736,503 | 17.7 M to 17.7 M (+0.14 %) |
Jul 23 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 24.36 | 25,000 | 609,000 | 17,711,503 | 17.7 M to 17.7 M (+0.14 %) |
Jul 23 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.76 | 50,000 | 1,188,000 | 17,686,503 | 17.6 M to 17.7 M (+0.28 %) |
Jul 20 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.60 | 50,000 | 1,180,000 | 17,636,503 | 17.6 M to 17.6 M (+0.28 %) |
Jul 20 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.78 | 50,000 | 1,189,000 | 17,586,503 | 17.5 M to 17.6 M (+0.29 %) |
Jul 20 2009 | ICN | VALEANT PHARMACEUT ... | ValueAct Holdings, L.P. | 10% Owner | Buy | P | 23.53 | 50,000 | 1,176,500 | 17,536,503 | 17.5 M to 17.5 M (+0.29 %) |